Qube Research & Technologies (QRT)’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
142,401
+31,870
+29% +$424K ﹤0.01% 2477
2026
Q2
$1.55M Buy
110,531
+55,421
+101% +$1M ﹤0.01% 2231
2026
Q1
$1.11M Buy
55,110
+46,059
+509% +$1.08M ﹤0.01% 2440
2025
Q4
$279K Buy
+9,051
New +$203K ﹤0.01% 2970
2024
Q1
– Sell
-425
Closed -$16.5K – 4707
2023
Q4
$16.5K Buy
+425
New +$15.3K ﹤0.01% 3518
2022
Q1
– Sell
-563
Closed -$87K – 2770
2021
Q4
$87K Buy
+563
New +$126K ﹤0.01% 2165
2021
Q3
– Sell
-2,275
Closed -$739K – 2547
2021
Q2
$739K Buy
+2,275
New +$746K 0.01% 1075

Other funds holding LYEL

Qube Research & Technologies (QRT)'s LYEL Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Lyell Immunopharma (LYEL) stake by 29% in Q3 2026, buying an estimated $424K and bringing the position to 142,401 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2477.

Qube Research & Technologies (QRT) first reported a position in LYEL in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.55M in Q2 2026. 105 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.

  • Qube Research & Technologies (QRT) held 142,401 shares of Lyell Immunopharma worth $1.39M as of Q3 2026.
  • Qube Research & Technologies (QRT) bought 31,870 Lyell Immunopharma shares in Q3 2026, an estimated $424K.
  • Lyell Immunopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2477 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Lyell Immunopharma position peaked at $1.55M in Q2 2026.
  • 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.